Outcome of 200 patients after an extracardiac Fontan procedure

Soo-Jin Kim1, Woong-Han Kim, Hong-Gook Lim

  • 1Department of Pediatric Cardiology, Sejong General Hospital, Sejong Heart Institute, Bucheon, Korea.

Insights

The extracardiac Fontan procedure shows good long-term outcomes, with high survival and functional status in patients. This study highlights satisfactory results for Fontan circulation, indicating a low incidence of complications like reoperation or thromboembolism.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease Surgery
  • Cardiovascular Surgery

Background:

  • The extracardiac conduit Fontan procedure offers advantages, but long-term conduit durability and anticoagulation outcomes require further evaluation.
  • Assessing long-term results is crucial for optimizing surgical strategies in complex congenital heart disease.

Purpose of the Study:

  • To evaluate the long-term outcomes of hospital survivors who underwent the extracardiac Fontan procedure.
  • To determine the longevity of the conduit and the effectiveness of anticoagulation therapy.

Main Methods:

  • Retrospective analysis of 200 patients undergoing extracardiac conduit Fontan operation between 1996 and 2006.
  • Kaplan-Meier survival and freedom from reoperation, arrhythmia, and thromboembolism analyses were performed.
  • Multivariate analysis identified risk factors for mortality and arrhythmia.

Main Results:

  • Ten-year overall survival was 92.4%.
  • Freedom from reoperation was 82.4%, freedom from arrhythmia was 85.1%, and freedom from thromboembolism was 92.9% at 10 years.
  • Severe early infection and preoperative pulmonary arterial pressure were risk factors for mortality; heterotaxy syndrome, follow-up duration, and age at operation were risk factors for arrhythmia. 95.2% of patients were in New York Heart Association class I.

Conclusions:

  • The extracardiac Fontan procedure demonstrates satisfactory long-term survival and functional status (NYHA Class I) over 10 years.
  • Fenestration may offer benefits, potentially mitigating risks in higher-risk patients.
  • Low incidences of late death, reoperation, pathway obstruction, arrhythmias, and thromboembolism suggest favorable long-term results.
Abstract